Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular CarcinomaMakoto Chuma, Shin Maeda, Toshifumi Tada et al.|Cancers|2020Cited by 54
Impact of body composition for patients with hepatocellular carcinoma who received atezolizumab plus bevacizumab therapyHaruki Uojima, Chika Kusano, Makoto Chuma et al.|European Journal of Gastroenterology & Hepatology|2023Cited by 9
A case of endoscopic hemostasis of ileal diverticular bleeding with ileal diverticulitisYosuke Nakamura, Masaaki Kondo, Hiroyuki Oka et al.|Progress of Digestive Endoscopy|2021Cited by 0